PharmAthene (PIP) Presents Data for Valortim(R) Anthrax Anti-Toxin and Third Generation rPA Anthrax Vaccine Programs
Tweet Send to a Friend
PharmAthene, Inc. (NYSE: PIP) announced that data from the Company's third generation recombinant protective antigen (rPA) anthrax vaccine program and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
